Primary biliary cirrhosis: What we know and what we want to know about human PBC and spontaneous PBC mouse models

Yoshiyuki Ueno, Yuki Moritoki, Tooru Shimosegawa, M. Eric Gershwin

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Human autoimmune cholangiopathy comprises several intractable liver diseases that ultimately lead to hepatic failure. Primary biliary cirrhosis (PBC), allograft rejection, graft versus host diseases, and, possibly, primary sclerosing cholangitis are representative of immune-mediated cholangiopathies. Among them, PBC is the best-investigated human autoimmune cholangiopathy. The immunological approach to PBC has provided much critical information regarding its pathogenesis. The breakdown of self-tolerance in both B cells and T cells toward E2 components of the pyruvate dehydrogenase complex is evident. However, a number of questions regarding its etiology are unclear, in particular, the mechanisms involved in the selectivity of cholangiocyte destruction. In this brief review, we discuss what we know and we do not know regarding the pathogenesis of PBC.

Original languageEnglish (US)
Pages (from-to)189-195
Number of pages7
JournalJournal of Gastroenterology
Volume42
Issue number3
DOIs
StatePublished - Mar 2007

Keywords

  • Animal model
  • Autoimmunity
  • Cholangiocyte
  • Cholestaticliver disease
  • Heterogeneity

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Primary biliary cirrhosis: What we know and what we want to know about human PBC and spontaneous PBC mouse models'. Together they form a unique fingerprint.

  • Cite this